Nodular Lymphocyte Predominant B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Nodular Lymphocyte Predominant B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial [Phase 2]
A National Cancer Institute–sponsored Phase 2 trial (NORM) is evaluating rituximab versus mosunetuzumab in nodular lymphocyte-predominant ly…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease [Phase 2]
Phase 2 clinical trial update evaluating treatment in young patients with newly diagnosed, low-stage lymphocyte-predominant Hodgkin disease.…